Author Archive: Michael Foster

Today we’re in a situation that looks a lot like 2016. And back then, some savvy contrarians tapped it to grab quick 62%+ returns. The same setup is back again—and so is our chance for more upside, plus yields north of 10%.

There are two closed-end funds (CEFs) poised to deliver those high yields (and overall returns); we’ll compare two popular options in a moment. First, let’s delve into the state of the corporate-bond market, because there are a lot of misconceptions floating around right now.

“Junk” Bonds Not as Risky as They Seem

You might know high-yield bonds by their nickname: junk bonds.… Read more

Municipal bonds are too often ignored by investors. Which is a huge missed dividend opportunity.

It’s too bad, because billionaires have been using “munis” to anchor their portfolios for years. And with good reason: as we’ll see in a second, munis can perform well when rates rise. They also pay a high “hidden” yield that beats anything you’d get on a Treasury—and most stocks.

“Munis” Offer Safe, High—and Tax-Free—Yields

I say munis’ yields are “hidden” because they’re tax-free. If you’re in a high tax bracket, I probably don’t have to tell you how valuable a tax-free yield is, but the numbers here are very compelling.… Read more

Some major—and almost totally ignored—news from Washington, D.C., is about to upend the biotech world, turning America into “the world’s pharmacy” in short order—and giving us a chance to buy a solid 6.8% dividend for just 91 cents on the dollar.

That might sound hard to believe for woebegone biotechs, which have fallen further than the S&P 500 this year, going by the performance of the benchmark iShares Biotechnology ETF (IBB). That’s despite the sector’s importance during the pandemic—and despite the fact that some 10,000 Americans turn 65 every day, sharply increasing demand for pharmaceuticals as the senior cohort grows.

Biotech Catches a Cold

The problem is that despite these tailwinds, biotech is weighed down by the same problems that are dragging on the rest of the economy: lower R&D funding as interest rates rise, and supply-chain issues that are hurting productivity.… Read more

Most folks don’t know it, but real estate has clobbered stocks in the long run, and it’s poised to pull off a win again in 2023.

And we dividend investors are nicely lined up to cash in, thanks to a fund throwing off a blockbuster 9.9% yield that’s the perfect play here. I’ll drop the name and ticker in a sec.

First, you read that right: real estate does outperform stocks over the long haul—and by no small amount, either! It’s clear as can be in this comparison between the SPDR Dow Jones REIT ETF (RWR), the index fund for publicly traded real estate investment trusts (REITs), and the S&P 500 over the last 20 years.… Read more

By now you’ve likely heard that September is the worst month for stocks. It’s all over the media! But September is also a great time to buy a unique type of dividend fund that cashes in when volatility rears up (these funds will pay you blockbuster yields north of 7%, too!).

I’m talking about a special type of closed-end fund (CEF) called a covered-call fund, which makes more money every time the market panics. They then turn that cash over to us in the form of a dividend that crushes anything you’d get on a blue-chip stock or Treasury.

Don’t let the jargon-y name throw you.… Read more

Whether you own a Treasury or the typical dividend stock these days, you’re still losing money after inflation.

I know what you’re thinking: tell me something I don’t know!

But there’s a solution hiding in plain sight: closed-end funds (CEFs), a widely overlooked (and publicly traded) asset class that often throws off rich payouts of 8% or more. We’ll do a deep dive into these scandalously overlooked income plays, and how they pay those big (and often monthly) dividends in a moment.

Here’s the top-line takeaway, though: by going with a CEF, you won’t have to sell the blue chips you own now.… Read more

One of the market’s smartest contrarian players just made a shocking move—and we dividend investors need to pay attention.

The contrarian in question? PIMCO, the company that revolutionized the humble closed-end fund (CEF). If you’re reading this, you’ve likely at least heard of CEFs, which are renowned for big dividend payouts: safe 7%+ yields are the hallmark of these (too) often-overlooked investment vehicles.

If you’ve never heard of PIMCO, all you need to know is that the company is to CEFs what Apple (AAPL) is to tech.

And PIMCO’s latest move is yet another signal that now is a great time to boost our positions in the 18 buy-rated funds in the CEF Insider portfolio.… Read more

Usually in a bear market like this, something is working somewhere. But I think you’ll agree that since the beginning of 2022, that “something” has been tough to nail down.

Treasuries are down some 23% on the year. And we know where the stock market has been.

Cash, of course, will always free you from stock- or bond-market volatility. But staying in cash too long leaves you exposed to today’s high inflation. And of course, cash pays zero dividends—and that’s just not an option for those of us looking to fund our retirements on dividends alone. That strategy largely allows you to tune out market volatility, which is why it’s a goal we aim for at my CEF Insider advisory.… Read more

There’s a group of dividend payers out there whose businesses are doing better than they were before the COVID mess, but their stocks are still ridiculously cheap today.

Best of all, we contrarian income seekers can get these stocks at an even deeper discount than regular folks can—while collecting a healthy 6.6% dividend.

The trick? Buy them through a closed-end fund (CEF) like the one we’ll discuss below.

But let’s not get ahead of ourselves. The investments we’re going to buy through this CEF are real estate investment trusts (REITs), which own and rent out various types of properties, from shopping malls to warehouses and cellphone towers.… Read more

When the market goes into the dumpster like it has in the last few months, one group of folks have an advantage: those who hold high-yield closed-end funds (CEFs).

If you haven’t already, now is a great time to join this group, thanks to the selloff. I’ll name an oversold bond fund that’s a great pick to start your CEF portfolio—or add to your current one—in a moment. It throws off a stable 7.5% payout that rolls your way monthly.

A 7.5%-Yielding “Dividend Lifeline”

Investors in “regular” stocks only wish they could get a payout like that. Unfortunately, the measly dividend on the typical S&P 500 stock (around 1.5%) means those who stick to the household names are reliant on price gains alone, so they’re forced to deal with sickening drops like the 2022 mess:

“Regular” Stock Investors Are Forced to Rely on This

To be sure, CEFs, like regular stocks, have fallen in the last few months, too.… Read more